- Home
- Products
- Prescription: cardiometabolic
- Verapamil-Darnitsa
Verapamil-Darnitsa
Cardioselective calcium channel blockers. Phenylalkylamine derivativesRelease forms:
- Film-coated tablets
- Solution for injection
– Ischemic heart disease, including stable angina; unstable angina (progressive angina, resting angina), vasospastic angina (Prinzmetal's variant angina), postinfarction angina in patients without heart failure, if b-blockers are not indicated.
– Arrhythmias: paroxysmal supraventricular tachycardia, atrial flutter/fibrillation with fast atrioventricular conduction (not including Wolff–Parkinson–White syndrome (WPW).
– Hypertension.
Characteristics of the productу:
- Release formThe tablet is indivisible
- ChildrenWith caution
- PregnantWith caution
- NursingWith caution
- Release categoryPrescription medication
- With alcoholWith caution
- DriversWith caution
- Temperature storage conditionsNot higher than 25 °С
- Qualitative and quantitative composition
- Pharmacological properties
- Clinical particulars
- Contraindications
- Interaction with other medicinal products and other forms of interaction
- Phenobarbital
- Buspirone
- Tacrolimus:possible increased plasma level of this drug
- Special warnings and precautions for use
- Relevant information on excipients
- Fertility, pregnancy and lactation. Pregnancy
- Lactation
- Effects on ability to drive and use machines
- Posology and method of administration
- Impaired renal function
- Impaired liver function
- Undesirable effects
- Kidney and urinary system disorders: unknown – renal failure
- Metabolism and nutrition disorders: unknown – hyperkalemia
- Special precautions for storage
- Nature and contents of container
- Сategory of release
- Manufacturer
- The manufacturer's location and address of the place of business
- Date of last revision